137 related articles for article (PubMed ID: 34315016)
1. Contrast agent retention features in contrast-enhanced ultrasound: diagnostic performance for the prediction of papillary thyroid carcinoma.
Jin Z; Zhu Y; Xie F; Zhang Y; Li N; Luo Y; Cao J
Clin Imaging; 2021 Dec; 80():131-138. PubMed ID: 34315016
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of Contrast-enhanced Ultrasound in Extrathyroidal Extension of Papillary Thyroid Carcinoma].
Cai Q; Luo Y; Li X; Lan Y; Zhang Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Oct; 42(5):619-625. PubMed ID: 33131516
[TBL] [Abstract][Full Text] [Related]
3. [Contrast-enhanced ultrasonography findings for papillary thyroid carcinoma and its pathological bases ].
Ma BY; Jin Y; Suntdar PS; Zhao HN; Jiang Y; Zhou JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):997-1000. PubMed ID: 25571732
[TBL] [Abstract][Full Text] [Related]
4. Correlation between maximum intensity and microvessel density for differentiation of malignant from benign thyroid nodules on contrast-enhanced sonography.
Jiang J; Shang X; Zhang H; Ma W; Xu Y; Zhou Q; Gao Y; Yu S; Qi Y
J Ultrasound Med; 2014 Jul; 33(7):1257-63. PubMed ID: 24958412
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer.
Zhang Y; Zhang X; Li J; Cai Q; Qiao Z; Luo YK
Eur Radiol; 2021 Jul; 31(7):4568-4575. PubMed ID: 33411051
[TBL] [Abstract][Full Text] [Related]
6. Value of Contrast-Enhanced Ultrasound in Partially Cystic Papillary Thyroid Carcinomas.
Fang F; Gong Y; Liao L; Ye F; Zuo Z; Qi Z; Li X; Niu C
Front Endocrinol (Lausanne); 2021; 12():783670. PubMed ID: 34956094
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement.
Wu Q; Wang Y; Li Y; Hu B; He ZY
Endocrine; 2016 Aug; 53(2):480-8. PubMed ID: 26732040
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.
Nemec U; Nemec SF; Novotny C; Weber M; Czerny C; Krestan CR
Eur Radiol; 2012 Jun; 22(6):1357-65. PubMed ID: 22322310
[TBL] [Abstract][Full Text] [Related]
9. Advantages of Routine Ultrasound Combined With Contrast-Enhanced Ultrasound in Diagnosing Papillary Thyroid Carcinoma.
Li F; Wang Y; Bai B; Wang S; Liu S
Ultrasound Q; 2017 Sep; 33(3):213-218. PubMed ID: 28832401
[TBL] [Abstract][Full Text] [Related]
10. Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules.
Friedrich-Rust M; Sperber A; Holzer K; Diener J; Grünwald F; Badenhoop K; Weber S; Kriener S; Herrmann E; Bechstein WO; Zeuzem S; Bojunga J
Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):602-9. PubMed ID: 19856256
[TBL] [Abstract][Full Text] [Related]
11. Value of time-intensity curve analysis of contrast-enhanced ultrasound in the differential diagnosis of thyroid nodules.
Gu F; Han L; Yang X; Liu H; Li X; Guo K; Zhao Z; Zhou X; Luo W
Eur J Radiol; 2018 Aug; 105():182-187. PubMed ID: 30017277
[TBL] [Abstract][Full Text] [Related]
12. Clinical Application of C-TIRADS Category and Contrast-Enhanced Ultrasound in Differential Diagnosis of Solid Thyroid Nodules Measuring ≥1 cm.
Jin Z; Zhu Y; Lei Y; Yu X; Jiang N; Gao Y; Cao J
Med Sci Monit; 2022 Jun; 28():e936368. PubMed ID: 35668611
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performances of various gray-scale, color Doppler, and contrast-enhanced ultrasonography findings in predicting malignant thyroid nodules.
Ma JJ; Ding H; Xu BH; Xu C; Song LJ; Huang BJ; Wang WP
Thyroid; 2014 Feb; 24(2):355-63. PubMed ID: 23978252
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Efficiency of Quantitative Contrast-Enhanced Ultrasound Indicators for Discriminating Benign From Malignant Solid Thyroid Nodules.
Zhou X; Zhou P; Hu Z; Tian SM; Zhao Y; Liu W; Jin Q
J Ultrasound Med; 2018 Feb; 37(2):425-437. PubMed ID: 28880412
[TBL] [Abstract][Full Text] [Related]
15. Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.
Liu Y; Liu H; Qian CL; Lin MS; Li FH
Sci Rep; 2017 May; 7(1):1472. PubMed ID: 28469180
[TBL] [Abstract][Full Text] [Related]
16. [Ultrasonographic assessment and differentiation of spontaneous degenerating cystic thyroid nodules and papillary thyroid carcinomas].
Huang XZ; Min X; Zhou AY; Zhu W; Yuan XC; Qi Q; Xiao F; Xu P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jan; 56(1):75-78. PubMed ID: 33472306
[No Abstract] [Full Text] [Related]
17. Value of CEUS features in diagnosing thyroid nodules with halo sign on B-mode ultrasound.
Chen XJ; Huang LJ; Mao F; Yuan HX; Wang X; Lu Q; Dong CH
BMC Med Imaging; 2023 Jan; 23(1):11. PubMed ID: 36681788
[TBL] [Abstract][Full Text] [Related]
18. Value of Contrast-Enhanced Ultrasound in Differentiating Clinically Atypical Subacute Thyroiditis from Papillary Thyroid Carcinomas.
Zhang Q; Liao L; Peng Q; Tang K; Xu Y; Zhang R; Liu M; Niu C
Ultrasound Med Biol; 2021 Dec; 47(12):3384-3392. PubMed ID: 34602283
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of thyroid imaging reporting and data system (TI-RADS) alone and in combination with contrast-enhanced ultrasonography for the characterization of thyroid nodules.
Zhao H; Liu X; Lei B; Cheng P; Li J; Wu Y; Ma Z; Wei F; Su H
Clin Hemorheol Microcirc; 2019; 72(1):95-106. PubMed ID: 30320563
[TBL] [Abstract][Full Text] [Related]
20. Correlation of contrast-enhanced ultrasonographic features with microvessel density in papillary thyroid carcinomas.
Zhou Q; Jiang J; Shang X; Zhang HL; Ma WQ; Xu YB; Wang H; Li M
Asian Pac J Cancer Prev; 2014; 15(17):7449-52. PubMed ID: 25227857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
